10x Genomics Completes $55 Million Series C Financing Round

On March 17, 2016, 10x Genomics, a company focused on improving and broadening the application of next generation sequencing genomic information, announced that it has closed a $55 million Series C round of financing led by Fidelity Management & Research Company, with participation from Softbank, JS Capital Management, Venrock, Foresite Capital, and Paladin Capital. Wilson Sonsini Goodrich & Rosati represented 10x Genomics in the transaction.

According to a 10x Genomics press release, the new financing will accelerate the company's marketing and sales efforts in support of its genome sequencing products, while fueling innovative future product development.

Corporate:
Dave Segre
Jennifer Knapp
Grant Reid

Intellectual Property:
Ali Alemozafar

For more information, please see 10x Genomics' press release.